What is the treatment of choice for urinary incontinence with a grade 2 cystocele and urge incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Incontinence with Grade 2 Cystocele and Urge Incontinence

For a patient with both grade 2 cystocele and urge incontinence, begin with pelvic floor muscle training (PFMT) combined with bladder training as first-line therapy, addressing the urge component before considering any surgical intervention for the cystocele. 1

Initial Conservative Management

First-Line Treatment: Combined Behavioral Therapy

  • Start with PFMT plus bladder training for this mixed presentation, as the American College of Physicians strongly recommends this combination for women with mixed urinary symptoms 1

  • PFMT should be initiated with proper instruction and supervision, as it has demonstrated efficacy in improving continence rates and quality of life 1

  • Bladder training specifically targets the urge incontinence component and has shown significant improvement in urgency symptoms 1

  • Do not proceed with surgical correction of the cystocele until the urge incontinence is adequately controlled, as uncontrolled overactive bladder symptoms can compromise surgical outcomes 1

Lifestyle Modifications

  • Recommend weight loss and exercise if the patient is obese, as this has strong evidence for improving incontinence 1

  • Advise reduction of bladder irritants including caffeine and alcohol 2

  • Address constipation if present, as it can exacerbate urinary symptoms 2

Second-Line Pharmacologic Treatment

When to Add Medications

  • If bladder training fails to adequately control urge incontinence after an appropriate trial (typically 6-12 weeks), add pharmacologic therapy 1

Medication Selection

  • Tolterodine is preferred over oxybutynin as both provide similar efficacy but tolterodine causes fewer adverse effects 1, 2

  • Alternative antimuscarinic options include darifenacin, solifenacin, fesoterodine, and trospium, all of which have demonstrated efficacy in increasing continence rates 1

  • Solifenacin has the lowest discontinuation rate due to adverse effects 2

  • Mirabegron (a beta-3 adrenergic agonist) is FDA-approved for overactive bladder and represents an alternative to antimuscarinics 3, 4

  • Base medication choice on tolerability, adverse effect profile, ease of use, and cost rather than efficacy, as most agents are similarly effective 1

Surgical Considerations

Timing of Surgical Intervention

  • The grade 2 cystocele should only be surgically addressed after the urge incontinence is controlled 1

  • Many women with stress urinary incontinence also have pelvic organ prolapse, and procedures can be performed concurrently when appropriate 1

  • However, in your patient's case, the predominant symptom is urge incontinence, not stress incontinence 1

Surgical Options (If Needed)

  • For the cystocele repair combined with any stress component: cadaveric prolapse repair with sling has shown acceptable outcomes for grade 2 cystoceles, with low recurrence rates (11.4% grade 1 recurrence) 5

  • Midurethral slings represent the gold standard for stress urinary incontinence if that component becomes problematic, with cure rates of 80-90% 1, 6

  • Do not use systemic pharmacologic therapy to treat any stress incontinence component, as it has not been shown to be effective 1

Critical Pitfalls to Avoid

  • Never perform cystocele surgery before controlling urge incontinence, as persistent urgency symptoms will compromise patient satisfaction and outcomes 1

  • Do not overlook medications that may cause or worsen incontinence (diuretics, alpha-blockers, sedatives) 1, 2

  • Avoid missing urinary tract infections or metabolic disorders that could be contributing to symptoms 1, 2

  • Do not assume the cystocele is causing the incontinence—grade 2 cystocele is moderate and the urge component is likely the primary driver of symptoms 5

  • Be aware that adverse effects are a major reason for medication discontinuation, so set appropriate expectations and monitor closely 1

Treatment Algorithm Summary

  1. Weeks 0-12: PFMT + bladder training + lifestyle modifications
  2. If inadequate response: Add antimuscarinic (preferably tolterodine) or mirabegron
  3. If urge incontinence controlled but stress component emerges: Consider pessary or continue PFMT
  4. Only after urge control: Evaluate need for cystocele repair based on symptoms and degree of bother
  5. If surgical intervention needed: Combine cystocele repair with anti-incontinence procedure if stress component present

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Urinary Urgency in Multiple Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.